HENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.

ABSTRACT:

SUBMITTER: Meijer LL 

PROVIDER: S-EPMC5153344 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature